| ²é¿´: 1722 | »Ø¸´: 7 | |||
| ¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß Ñ§Ô±JYzuYE µÄ 10 ¸ö½ð±Ò | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
zwjxyzclÌú³æ (³õÈëÎÄ̳)
|
[½»Á÷]
JMCC reject&resubmission´ó¼Ò°ïæ¿´¿´
|
||
|
ͶÐÄѪ¹ÜµÄJMCC ½á¹û±»reject&resubmission£¬±à¼ºÃÏñûÌá³öʲôÒâ¼û¡£Éó¸åÈ˵ÄÒâ¼û¸Ð¾õ·ÖÆçºÜ´ó°¡£¬review1¸Ð¾õ²¢Ã»ÓÐϸ¿´ÎÄÕ Á¬¶ÔÎÒÎÄÕµÄÃèÊö¶¼´íÁË2´¦¡£¶øºó2¸öÉó¸åÈËÒâ¼û»¹±È½Ï²»´í£¬¼¸ºõ²»ÐèÒª²¹ÊµÑ飬ֻÊÇÒªÈóÉ«ÎÄÕ ´ð´ðÎÊÌâ¡£ÒòΪreview1µÄÒâ¼û¸ÄÆðÀ´¹À¼Æ¶¼¿ÉÒÔ·¢ÆªSCIÁË£¨¼û¹ýһƪ5·ÖµÄÎÄÕÂ×ö¹ýÉÏÓΣ©£¬¿ÉÄÜÎÞ·¨Ð޸쬶øÇÒÎҸоõËû¶ÔÎÒÃÇÓÐЩƫ¼û£¬ÅÂÊÇÔõô¸Ä¶¼Ã»Óᣡ£¡£¡£ÇëÕ½ÓÑÃÇ·ÖÎöÏ£¬ÖØÍ¶ÖеĿÉÄÜÐÔ´óô¡£¡£¡£¡£»á²»»á»»¸öÉó¸åÈËÄØ£¬ÒÔϸ½Éó¸åÒâ¼û£º Reviewer #1: The authorstried to show the involvement of mir-145 for CD-137 induced migration ofvascular smooth muscle cells. The concept is too complex and data qualityis not good. Composition of manuscript is not good. Manuscript included the manyof type-miss, mixed with some non-english characters. 1) Authors mentioned CD-137 down-regulate mir145, which leaded to down regulation of NFATc1 but In Fig 2A the expression ofNFATc1 with CD137 is very small. Data quality is not generally good, thus, I donot recommend the manuscript for publication. Reviewer #2: Yan et alshowed that CD137 accelerated neointima formation and VSMCs proliferation andmigration in vivo and in vitro. Mechanistically, miR145 was downregulated andresulted in increased NFATc1 expression in VSMCs upon treatment with agonisticCD137 antibody. To investigate why VSMCs phenotype transformed, the authorsshowed that overexpression of miR145 or NFATc1 deficiency could rescue the VSMCtransformation led by CD137. This is a well design and performed manuscript.There will be interesting for the readers of JMCC. However, this manuscript canbe strengthened with the following revision: Major comments Reviewer #3: The study byYan et al. showed that CD137, a protein belonging to the TNF superfamily,induces vascular smooth muscle cell dedifferentiation through down regulatingmiR-145 and up-regulating NFATc1. Previously many reports showed that miR-145could modulate the fate of smooth muscle cells In this study, the authorsshowed that miR-145 targets NFATc1 mRNA to reduces its expression, which is anovel finding. In general, the study design is logic and the data aresupporting the hypothesis. However, there are multiple issues with the study: |
» ²ÂÄãϲ»¶
»ù½ðϵͳʲôÄÚÈÝҲûÓÐ
ÒѾÓÐ6È˻ظ´
ÓжàÉÙÈËÊǽñÌì²éϵͳ֪µÀ½á¹ûµÄ£¿
ÒѾÓÐ17È˻ظ´
¹ú×ÔÈ»ÃæÉϸ´ÅÌ~»¶ÓÌÖÂÛ
ÒѾÓÐ12È˻ظ´
Ϊʲô×ÊÖúÊý¸÷´ó¸ßУ¶¼´´Ð¸ߣ¬×Ô¼ºÉêÇëÔõô¾ÍÕâôÄÑ
ÒѾÓÐ9È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8O5.5.1.O5.4,¿ÆÄ¿È«,¿ÉÙ¤¼±
ÒѾÓÐ3È˻ظ´
ÄÄλ¸ßÈËÖÐÁË£¬°Ñ²éѯµ½µÄ½ØÍ¼Ìù³öÀ´ÈÃÎÒ¿´¿´£¬ÈÃÎÒ³¤³¤¼ûʶ
ÒѾÓÐ6È˻ظ´
ÊÛSCIÎÄÕ£¬ÎÒ:8O5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ4È˻ظ´
ÃæÉϺÏ×÷µ¥Î»¸ÇÕÂ
ÒѾÓÐ5È˻ظ´
µ¼Ê¦Í²ۣºÎÒÔõô̯ÉÏÁËÕâô¸ö¼«Æ·Ñо¿Éú£¡
ÒѾÓÐ7È˻ظ´
ÉêÇëɾ³ý±¾Ìû
ÒѾÓÐ7È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
RSC ¡°reject and resubmssion¡±£¬Ï´ÎͶ¸åÊÇͶ×îÖÕ״̬µÄ¸å¼þ»¹ÊÇͶ´øÐÞ¶©Ä£Ê½µÄ
ÒѾÓÐ32È˻ظ´
ͶJMCCÒªÇóReject & Resubmit
ÒѾÓÐ24È˻ظ´
Reject with encouragement for resubmission (Major revision)ÊÇɶÒâ˼°¡£¡£¡
ÒѾÓÐ12È˻ظ´
resubmission & reject Çë½Ì´óÉñ°ïæ
ÒѾÓÐ17È˻ظ´
reject and resubmission ´ó¼Ò¸øÎÒ¿´¿´Éó¸åÒâ¼û
ÒѾÓÐ31È˻ظ´
RSCÔÓÖ¾Reject & Resubmit ´ó¼Ò¿´¿´ÖØÍ¶Ï£Íû´ó²»
ÒѾÓÐ14È˻ظ´
reject & resubmission »¹ÓÐÏ·Âð£¿
ÒѾÓÐ16È˻ظ´
ÔÞÒ»ÏÂJournal of Materials chemistry
ÒѾÓÐ18È˻ظ´
WolfYang
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
- Ó¦Öú: 138 (¸ßÖÐÉú)
- ½ð±Ò: 16895.4
- ºì»¨: 11
- Ìû×Ó: 3080
- ÔÚÏß: 932.3Сʱ
- ³æºÅ: 2496982
- ×¢²á: 2013-06-05
- רҵ: Á¦Ñ§ÖеĻù±¾ÎÊÌâºÍ·½·¨
¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
|
ÄãÏȰ´Éó¸å2ºÍ3µÄÒâ¼ûÐ޸ģ¬Éó¸åÈË1µÄÒâ¼û ÄÜÐ޸ľ͸쬲»Äܵϰ£¬Ð´·ÝÏêϸÀíÓÉ˵Ã÷ת½»¸øreviewer 1¡£ÆäʵÈç¹ûÓÐÁ½¸öÕýÒâ¼û¾Í¿ÉÒÔ£¬ÎÒÏëÕâ¾ÍÊDZà¼ÈÃÄãÖØÍ¶µÄÔÒò£¬ËûÖ»ÊDz»ÈÏ¿ÉÄ㵱ǰ°æ±¾µÄÂÛÎÄ£¬¶à»¨µÄʱ¼äºÃºÃ¸Ä£¬Ó¦¸ÃÄܽÓÊܵġ£Ò»¶¨ÒªÈÏÕæ¶Ô´ýÆäËûÁ½¸öÉó¸åÈËÒâ¼û£¡ [ ·¢×ÔÊÖ»ú°æ https://muchong.com/3g ] |
4Â¥2015-06-14 19:03:33
listensea8318
Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 70 (³õÖÐÉú)
- ½ð±Ò: 1389.1
- É¢½ð: 13314
- ºì»¨: 15
- Ìû×Ó: 8961
- ÔÚÏß: 384.9Сʱ
- ³æºÅ: 656999
- ×¢²á: 2008-11-18
- ÐÔ±ð: GG
- רҵ: ½»²æÑ§¿ÆÖеĹâѧÎÊÌâ

3Â¥2015-06-14 16:55:55
ljq158
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 227 (´óѧÉú)
- ½ð±Ò: 19713.2
- É¢½ð: 2519
- ºì»¨: 42
- Ìû×Ó: 6795
- ÔÚÏß: 2093.5Сʱ
- ³æºÅ: 1681876
- ×¢²á: 2012-03-11
- רҵ: »¯¹¤ÏµÍ³¹¤³Ì
¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
| Ï£ÍûºÜ´ó£¬However,Èç¹û±à¼ÖØÐÂÕÒÉó¸åÈ˾ÍÄÑ˵£¬ÒÔǰ¾ÍÓöµ½¹ý reject and resubmission£¬Òâ¼û·µ»ØÈ¥£¬±à¼Ã»ËÍÔÀ´Éó¸åÈË£¬¶øÊÇÖØÐÂÕÒÁ˸üÑϸñµÄÉó¸åÈË£¬½á¹û±»¾Ü¡£ |
5Â¥2015-06-14 19:29:16
zwjxyzcl
Ìú³æ (³õÈëÎÄ̳)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 327.1
- Ìû×Ó: 50
- ÔÚÏß: 13.5Сʱ
- ³æºÅ: 2728177
- ×¢²á: 2013-10-16
- רҵ: ¶¯ÂöÖàÑùÓ²»¯Ó붯ÂöÓ²»¯
6Â¥2015-06-17 20:33:29









»Ø¸´´ËÂ¥
30
ͶƱ: